WHO vaccine-preventable diseases: monitoring system. 2018 global summary

Last updated 22-Oct-2018 (data as of 18-Sep-2018)
Next overall update spring 2019
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 7'8901 Infant (under 12 months) mortality rate: 102
GDP / capita (US$): 26'4101 Child (under 5 years) mortality rate: 112

Population data in thousands3

  2017  2016  2015  2014  2013  2000  1990  1980 
Total population 18'204  17'988  17'750  17'488  17'207  15'057  16'540  14'906 
Births 373  380  385  388  390  239  383  381 
Surviving infants 368  375  380  383  384  229  363  356 
Pop. less than 5 years 1'970  1'997  1'991  1'956  1'893  1'115  1'878  1'701 
Pop. less than 15 years 5'084  4'929  4'753  4'574  4'388  4'152  5'198  4'820 
Female 15-49 years 4'557  4'565  4'579  4'599  4'619  4'139  4'135  3'819 

Number of reported cases

(Click for retrospective incidence data for Kazakhstan)
Diphtheria
ChartChart
  13  28 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  122  526  321  73  245  273 
Mumps
ChartChart
  39  24  25  40  38  3'236 
Pertussis
ChartChart
  44  32  74  23  14  87  395 
Polio*
ChartChart
 
Rubella
ChartChart
  152  36  14'989 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Kazakhstan)
Vaccine year result method % card seen                                                
BCG 2014  99  MICS   98  95  95  95  95  95  98 
DTP1 2014  96  MICS   98  99*  93  99  96  99  97 
DTP3 2014  92  MICS   98  99*  83  98  95  98  97 
DTP4          89  95  96  95 
IPV1          99*  93  99  96 
HepB_BD          90  95  95  95  95  98 
HepB3 2014  90  MICS   98  99*  83  98  95  99  99* 
Hib3 2014  91  MICS   98  99*  83  98  95  98 
JapEnc         
MCV1          99*  99  99*  99  99*  99 
MCV2          99  99  98  99  99  99* 
MenA         
PCV1          98  99*  93  70  62 
PCV2          97  98  85  65  58 
PCV3          98  97  74  58  52 
Pol3 2014  91  MICS   98  99*  83  98  95  98  97 
Rota1         
RotaC         
RCV1          99*  99  99*  99  99* 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2019

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Kazakhstan)
BCG
ChartChart
  95  95  95  95  95  98 
DTP1
ChartChart
  99  93  99  96  99  98 
DTP3
ChartChart
  99  82  98  95  98  97 
HepB3
ChartChart
  99  82  98  95  99  99 
HepB_BD
ChartChart
  90  95  95  95  95  98 
Hib3
ChartChart
  99  82  98  95  98 
IPV1
ChartChart
  99  93  99 
MCV1
ChartChart
  99  99  99  99  99  99 
MCV2
ChartChart
  99  99  98  99  99  98 
PCV3
ChartChart
  98  97  74  58  52 
Pol3
  99  82  98  95  98  96 
RCV1
ChartChart
  99  99  99  99  99 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 211  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2017 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
Anthrax No permanently disadvantaged places and the risk group for professional activities
BCG birth; 6 years; Yes
DTaPHibHepBIPV 2, 4 months; Yes
DTaPHibIPV 3, 18 months; Yes
HepA_Adult Yes contact in foci of HAV
HepA_Pediatric 2, 2.5 years; Yes
HepB_Adult Yes medical workers, contact in foci, blood recipients
HepB_Pediatric birth; Yes
Influenza_Adult >=65 years; Yes and adults with chronic illness, pregnant women, health care workers, residents of long-term care facilities
Influenza_Pediatric Yes and children with chronic illness
MMR 1, 6 year; Yes
OPV 12 months; Yes
plague No
Pneumo_conj 2, 4, 12 months; Yes
Rabies Yes by indications
TBE No inhabitants of endemic territories
Td 16, 26, 36, 46, 56 years; Yes
Tdap 6 years; Yes
Tularemia No

Immunizaton indicators

Indicator Expected answer 2017  2016  2015  2014  2013  2012  2011 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   
What years does the MYP cover? number 2016-2019      2011-2015    2012-2015   
Nº of districts with microplans that include activities to raise immunization coverage number 211  211  204  204  204    205 

System performance

Total Nº districts in country number 211  211  204  204  204  204  205 
Nº districts with DTP3 coverage >=80% number 211  79  204  204  204    205 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  37  100  100  100    100 
Nº districts with measles (MCV1) coverage >=95% number 205  211  204  204  204    205 
% of districts with MCV1 coverage >=95% From 0 to 100% 97  100  100  100  100    100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  No  No  No  Yes  No  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100       

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2018, data for 2016
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.